PharmaMar Partners with Foundation for Women’s Cancer to Support D.C. National 5K Race

PharmaMar Partners with Foundation for Women’s Cancer to Support D.C. National 5K Race
Spain's PharmaMar partnered with the Foundation for Women's Cancer (FWC) on Nov. 5 to support the 8th National Race to End Women’s Cancer in Washington, D.C. The race featured a 5k run and a one-mile walk along Pennsylvania Avenue, as well as other activities involving patients and families. Established in 2009, the race is open to anyone wishing to participate, including physicians and healthcare professionals. “We're very excited and appreciative to have PharmaMar join the movement by sponsoring the 8th National Race to End Women's Cancer," Karen Carlson, executive director of the FWC, said in a press release. "We look forward to building upon our new partnership as we strive to increase public awareness of gynecologic cancer risk awareness, prevention, early detection and optimal treatment.” Added Pascal Besman, chief operating officer of PharmaMar USA: "It is a wonderful opportunity for us to partner with the 'National Race to End Women's Cancer' given their tremendous reach in the entire women's cancer community of patients, caregivers, physicians, advocates and others, and given our extensive clinical trials for Zepsyre in three of these cancers. I am honored to represent PharmaMar as a proud participant in this important event." PharmaMar is currently awaiting data, expected in 2018, from its pivotal Phase 3 CORAIL clinical trial (
Subscribe or to access all post and page content.